Skip to main navigation Skip to search Skip to main content

Comparison of safety profiles for dapagliflozin based on EMA and FDA safety issues: Challenges and future of post-marketing surveillance in Korea

  • Suvin Park
  • , Hee Jin Kim
  • , Heehyun Won
  • , Hui Eon Lee
  • , Haerin Cho
  • , Nam Kyong Choi

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Comparison of safety profiles for dapagliflozin based on EMA and FDA safety issues: Challenges and future of post-marketing surveillance in Korea'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science